References
Li T, Yu J, Chen Y et al (2020) Preventive intraperitoneal hyperthermic perfusion chemotherapy for patients with T4 stage colon adenocarcinoma. Tech Coloproctol. https://doi.org/10.1007/s10151-020-02270-1
Snaebjornsson P, Coupe VM, Jonasson L et al (2014) pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited. Int J Cancer 135:467–478
Hompes D, Tiek J, Wolthuis A et al (2012) HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol 23:3123–3129
Klaver CEL, Wisselink DD, Punt CJA et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol 4:761–770
Arjona-Sánchez A, Barrios P, Boldo-Roda E et al (2018) HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma. BMC Cancer 18:183
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Arjona-Sanchez has nothing to disclose.
Ethical approval
This article does not contain any study with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Arjona-Sánchez, A. Hyperthermic intraperitoneal chemotherapy as adjuvant therapy in locally advanced colon cancer. Tech Coloproctol 25, 147–148 (2021). https://doi.org/10.1007/s10151-020-02304-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-020-02304-8